Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-20), Centrum Medyczne ENEL-MED's 3-1 Month Momentum % is 2.33%.
The industry rank for Centrum Medyczne ENEL-MED's 3-1 Month Momentum % or its related term are showing as below:
FRA:E19's 3-1 Month Momentum % is ranked better than 54.33% of 670
companies
in the Healthcare Providers & Services industry
Industry Median: 0.61
vs FRA:E19: 2.33
Centrum Medyczne ENEL-MED (FRA:E19) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Centrum Medyczne ENEL-MED 3-1 Month Momentum % Related Terms
FRA:E19 vs HCA, THC, EHC: 3-1 Month Momentum % Comparison
For the Medical Care Facilities subindustry, Centrum Medyczne ENEL-MED's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Centrum Medyczne ENEL-MED 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Centrum Medyczne ENEL-MED's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Centrum Medyczne ENEL-MED's 3-1 Month Momentum % falls into.
Centrum Medyczne ENEL-MED (FRA:E19) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Centrum Medyczne ENEL-MED (FRA:E19) has a 3-1 Month Momentum % of 2.33% as of Sep. 20, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Centrum Medyczne ENEL-MED and its competitors. According to the industry distribution chart, Centrum Medyczne ENEL-MED ranks #306 out of 670 companies in the Healthcare Providers & Services industry, placing it in the top 45.7%.
Is Centrum Medyczne ENEL-MED's 3-1 Month Momentum % too high?
Centrum Medyczne ENEL-MED's current 3-1 Month Momentum % is 2.33%. The Healthcare Providers & Services industry median 3-1 Month Momentum % is 0.61. Centrum Medyczne ENEL-MED's value of 2.33% is 282% above this industry median. Based on the distribution chart, Centrum Medyczne ENEL-MED ranks #306 out of 670 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Centrum Medyczne ENEL-MED has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Centrum Medyczne ENEL-MED's 3-1 Month Momentum % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Centrum Medyczne ENEL-MED ranks #306 out of 670 companies for 3-1 Month Momentum %. This puts Centrum Medyczne ENEL-MED in the upper half of its industry. The industry median 3-1 Month Momentum % is 0.61. Centrum Medyczne ENEL-MED's value of 2.33% is 282% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
The median 3-1 Month Momentum % among Healthcare Providers & Services companies is 0.61, based on 670 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Centrum Medyczne ENEL-MED's current 3-1 Month Momentum % of 2.33% is 282% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Centrum Medyczne ENEL-MED and its competitors. For the Healthcare Providers & Services industry, the median 3-1 Month Momentum % is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Centrum Medyczne ENEL-MED's current 3-1 Month Momentum % is 2.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Centrum Medyczne ENEL-MED stock overvalued right now?
Centrum Medyczne ENEL-MED (FRA:E19) has a current 3-1 Month Momentum % of 2.33%. The stock's GF Value™ is €5.59, compared to a current price of €4.36 — trading 22% below its estimated fair value. The current 3-1 Month Momentum % is 2.33% and 282% above the Healthcare Providers & Services industry median of 0.61. Centrum Medyczne ENEL-MED's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Centrum Medyczne ENEL-MED (FRA:E19), the current 3-1 Month Momentum % is 2.33% as of Sep. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Centrum Medyczne ENEL-MED (FRA:E19) Overvalued in 2026?
Based on GuruFocus' analysis, Centrum Medyczne ENEL-MED stock appears to be undervalued.
The current stock price of €4.36 is trading 22% below its estimated GF Value™ of €5.59.
Key valuation signals for FRA:E19:
3-1 Month Momentum %: 2.33%
GF Value™: €5.59 vs. price of €4.36 (22% below fair value)
Industry Position: 282% above the Healthcare Providers & Services median (#306 of 670)
No single metric tells the full story. See the FRA:E19 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Centrum Medyczne ENEL-MED SA is engaged in providing medical services throughout Poland region. The company is involved in providing various services that are dentistry, picture diagnosis, clinics, subscription for companies, and medical insurance. It also provides hospitals, aesthetic medicines, and sports medicine. The company's treatment cycle consists of consultation, diagnosis, hospitalization, surgery, and rehabilitation.
80GF Score
Get the complete analysis for FRA:E19
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:E19 has been successfully added to your 
